INDIANAPOLIS — Three Indiana University School of Medicine faculty have been recognized among the nation's top physician-scientists as 2025 members of the American Society for Clinical Investigation (ASCI).
New ASCI members will be inducted on Friday, April 25 as part of this year's joint meeting of the ASCI, the Association of American Physicians, and the American Physician Scientists Association.
The ASCI is a nonprofit medical honor society comprised of over 3,000 physician-scientists representing all medical specialties and dedicated to the advancement of research that extends understanding of diseases and improves treatment. According to its website, ASCI recommends up to 100 candidates for election each year based on "outstanding scholarly achievement."
IU School of Medicine's 2025 ASCI members are:
"Election as a member of the ASCI is a tremendous honor in the career of a physician-scientist," said Tatiana Foroud, PhD, executive associate dean for research affairs at the IU School of Medicine. "I'm thrilled that Drs. Hato, Eadon and Sims are being recognized for their outstanding research achievements."
Sims, an associate professor of pediatrics at the IU School of Medicine, focuses on underlying mechanisms, biomarkers and practical applications of beta cell dysfunction in Type 1 diabetes to directly benefit patients.
"This is such a huge honor for me, and it is really icing on the cake because I already feel so lucky to get to work in a field that I enjoy and has potential to impact our patients," Sims said. "As my own career has matured, I have also had the opportunity to get more involved in developing the next generation of physician scientists and so am especially looking forward to learning about more resources and opportunities to do this through ASCI offerings."
Eadon, the David M. and Julie B. DeWitt Scholar in Nephrology Research at the IU School of Medicine, studies the relationship between transcriptomic and genomic markers to help improve drug efficacy and adverse events relevant in kidney disease.
"IU School of Medicine provides a vibrant academic environment," Eadon said. "To have three inductees this year shows that IU is committed to developing and retaining its investigators. I am proud to represent IU School of Medicine nephrology and clinical pharmacology in the ASCI."
Hato, an associate professor of medicine at the IU School of Medicine, studies the cellular and molecular mechanisms of sepsis-associated acute kidney injury, the most common kidney problem in hospital settings.
"I am deeply grateful to my mentors, colleagues, and the research community for their support and inspiration," Hato said. "This is a tremendous honor that reinforces my commitment to advancing biomedical research and contributing to the success of others in the field."
IU School of Medicine faculty previously inducted into the ASCI include Liana Apostolova, Carmella Evans-Molina, David Hains, Asok C. Antony, David M. Aronoff, Karl Bilimoria, D. Craig Brater, Naga Chalasani, D. Wade Clapp, David Crabb, Michael J. Econs, Tarek M. Ashkar (El-Achkar), Laura S. Haneline, Jay L. Hess, David A. Ingram Jr., Roberto F. Machado, Meena Madhur, Sharon M. Moe, Bruce A. Molitoris, G. David Roodman, Stanley M. Spinola, Stephanie M. Ware and Michael A. Weiss.
About the Indiana University School of Medicine
The IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability. According to the Blue Ridge Institute for Medical Research, the IU School of Medicine ranks No. 13 in 2023 National Institutes of Health funding among all public medical schools in the country.
For more news, visit the IU School of Medicine Newsroom: medicine.iu.edu/news